BioVaxys Vaccine Platform Stimulates Robust T-cell Response Ag... - 22 December 2020 00:00

VANCOUVER, B.C., Dec. 21, 2020 /PRNewswire-AsiaNet/ -- - BVX-0320 ACTIVATES IMMUNE SYSTEM MEMORY 'HELPER ' CD4+ AND KILLER CD8+ T-CELLS AGAINST SARS-COV-2 - POTENTIAL FOR LONGER-TERM VIRAL PROTECTION BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTC:LMNGF) ("BioVaxys") announced today that furt...

  Sifi Launches Well Fusion, A Novel Presbyopia Correcting System - 21 December 2020 22:00

CATANIA, Italy, Dec. 21, 2020 /PRNewswire-AsiaNet/ -- - Spectacle-free uninterrupted high-quality vision for cataract patients SIFI, a leading international eye care company, today announces the launch of the WELL FUSION(TM) system and the Mini WELL PROXA(R) intraocular lens, offering a novel ...

  Occlutech’s Atrial Flow Regulator (AFR) Receives U.S. FDA Brea... - 19 December 2020 01:10

SCHAFFHAUSEN, Switzerland, Dec 18, 2020 /PRNewswire-AsiaNet/ -- Occlutech, a privately-held company, announced today that the US Food and Drug Administration (FDA) has granted the company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for Pulmonary Arterial Hy...

  Small vessels can cause big problems; MagicTouch SCB Granted '... - 18 December 2020 06:20

TAMPA, Fla., Dec. 18, 2020 /PRNewswire-AsiaNet/ -- Concept Medical Inc. [https://www.conceptmedical.com/] (CMI) has been granted "Breakthrough Device Designation" [ https://www.conceptmedical.com/press-release/magictouch-scb-granted-breakthrough-device-designation/] from the Center for Devices...

  Global Extracorporeal Membrane Oxygenation (ECMO) Devices Mark... - 17 December 2020 12:00

PUNE, India, Dec. 17, 2020 /PRNewswire/ AsiaNet/ -- - The global extracorporeal membrane oxygenation (ECMO) devices market was estimated to be US$ 308.10 million in 2019. Request for Sample Copy of This Report@ https://www.absolutemarketsinsights.com/request_sample.php?id=758 - T...

  Global CT Scanner Market is expected to reach US$ 9.07 billion... - 17 December 2020 11:00

PUNE, India, December 17 /PRNewswire-AsiaNet/ -- - The global CT scanner market was valued at US$ 5.01 billion in 2019 and is expected to reach US$ 9.07 billion by 2028. Request for Sample Copy of This Report@ https://www.absolutemarketsinsights.com/request_sample.php?id=757 ...

  Tianjin Jinyun New Media Group presents a video on Scientific ... - 17 December 2020 03:50

TIANJIN, China, December 17, 2020, /PRNewswire-AsiaNet/-- Traditional Chinese Medicine has played an important role in the worldwide fight against COVID-19. This short video introduces TCM's cultural inheritance, anti-epidemic achievements, its scientific and technological innovation and its efforts to s...

  New data confirms Smith+Nephew technology as the best performi... - 17 December 2020 00:00

LONDON, Dec. 17, 2020 /PRNewswire-AsiaNet/ -- -- Components of the POLAR3(TM) Total Hip Solution excel at ten and fifteen year benchmarks in global registries Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced outstanding clinical results for its tota...

  APRINOIA Therapeutics Established Collaboration on Tau PET Ima... - 16 December 2020 13:08

TAIPEI, Dec. 16, 2020 /PRNewswire-AsiaNet/ -- APRINOIA Therapeutics Inc. today announced that they had executed a worldwide non-exclusive licensing agreement for Biogen Inc. (Nasdaq: BIIB) to access APRINOIA's positron emission tomography (PET) imaging tracer, [18F]-APN-1607, for neurodegener...

  RedHill's Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-R... - 16 December 2020 02:07

TEL AVIV, Israel and RALEIGH, N.C., December 15, 2020, /PRNewswire-AsiaNet/-- RedHill Biopharma Ltd. [https://www.redhillbio.com/RedHill/ ] (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced promising preliminary results from a preclinical study within which opaganib, a nove...